M. Conces Et Al. , "Total neoadjuvant therapy (TNT) in early-onset (EO) vs average-onset (AO) locally advanced rectal cancer (LARC): Patient characteristics and tolerance," ANNALS OF ONCOLOGY , vol.33, 2022
Conces, M. Et Al. 2022. Total neoadjuvant therapy (TNT) in early-onset (EO) vs average-onset (AO) locally advanced rectal cancer (LARC): Patient characteristics and tolerance. ANNALS OF ONCOLOGY , vol.33 .
Conces, M., Gorgun, E., Tursun, N., ÖZGÜR, İ., Elamin, D., Yilmaz, S., ... Patil, S.(2022). Total neoadjuvant therapy (TNT) in early-onset (EO) vs average-onset (AO) locally advanced rectal cancer (LARC): Patient characteristics and tolerance. ANNALS OF ONCOLOGY , vol.33.
Conces, M. Et Al. "Total neoadjuvant therapy (TNT) in early-onset (EO) vs average-onset (AO) locally advanced rectal cancer (LARC): Patient characteristics and tolerance," ANNALS OF ONCOLOGY , vol.33, 2022
Conces, M. Et Al. "Total neoadjuvant therapy (TNT) in early-onset (EO) vs average-onset (AO) locally advanced rectal cancer (LARC): Patient characteristics and tolerance." ANNALS OF ONCOLOGY , vol.33, 2022
Conces, M. Et Al. (2022) . "Total neoadjuvant therapy (TNT) in early-onset (EO) vs average-onset (AO) locally advanced rectal cancer (LARC): Patient characteristics and tolerance." ANNALS OF ONCOLOGY , vol.33.
@article{article, author={M. Conces Et Al. }, title={Total neoadjuvant therapy (TNT) in early-onset (EO) vs average-onset (AO) locally advanced rectal cancer (LARC): Patient characteristics and tolerance}, journal={ANNALS OF ONCOLOGY}, year=2022}